Regardless, since protein dyshomeostasis unifies several neurodegenerative diseases, and given the functional resemblance between RBPs, it is plausible to hypothesize that targeting ribonucleoprotein particle (RNP) assembly in human neurodegenerative diseases could be an effective strategy in the treatment of NDs. The gene discussed is RNPC3; the disease is neurodegenerative disease.